Industry Satellite Symposium Auditorium 2

Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines

Date
Wed, 29.03.2023
Time
18:15 - 19:45
Room
Auditorium 2
Chairs
  • S. Peters (Lausanne, Switzerland)
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines (ID 39) Industry Satellite Symposium

Welcome and introduction

Lecture Time
18:15 - 18:20
Speakers
  • S. Peters (Lausanne, Switzerland)
Authors
  • S. Peters (Lausanne, Switzerland)
Session Name
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines (ID 39)
Date
Wed, 29.03.2023
Time
18:15 - 19:45
Room
Auditorium 2
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines (ID 39) Industry Satellite Symposium

Key considerations for the treatment of patients pre-treated with checkpoint inhibitors and chemotherapy

Lecture Time
18:20 - 18:40
Speakers
  • S. Peters (Lausanne, Switzerland)
Authors
  • S. Peters (Lausanne, Switzerland)
Session Name
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines (ID 39)
Date
Wed, 29.03.2023
Time
18:15 - 19:45
Room
Auditorium 2
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines (ID 39) Industry Satellite Symposium

Tumour microenvironment manipulations to improve patients outcomes: A translational review

Lecture Time
18:40 - 19:00
Speakers
  • F. Barlesi (Villejuif, France)
Authors
  • F. Barlesi (Villejuif, France)
Session Name
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines (ID 39)
Date
Wed, 29.03.2023
Time
18:15 - 19:45
Room
Auditorium 2
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines (ID 39) Industry Satellite Symposium

Debate on chemotherapy use in high PD-L1 expressors: The pros and cons

Lecture Time
19:00 - 19:20
Speakers
  • N. Leighl (Toronto, Canada)
Authors
  • N. Leighl (Toronto, Canada)
  • L. Paz-Ares (Madrid, Spain)
Session Name
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines (ID 39)
Date
Wed, 29.03.2023
Time
18:15 - 19:45
Room
Auditorium 2
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines (ID 39) Industry Satellite Symposium

Expert panel discussion

Lecture Time
19:20 - 19:40
Session Name
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines (ID 39)
Date
Wed, 29.03.2023
Time
18:15 - 19:45
Room
Auditorium 2
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines (ID 39) Industry Satellite Symposium

Conclusion

Lecture Time
19:40 - 19:45
Speakers
  • S. Peters (Lausanne, Switzerland)
Authors
  • S. Peters (Lausanne, Switzerland)
Session Name
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines (ID 39)
Date
Wed, 29.03.2023
Time
18:15 - 19:45
Room
Auditorium 2